相关实验视频

Updated: Jun 4, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

诱导多能干细胞衍生自然杀伤细胞疗法的进展

Wenhua Qiao¹, Peng Dong², Hui Chen^1,2

¹CAMS Key Laboratory for T Cell and Immunotherapy, State Key Laboratory of Common Mechanism Research for Major Diseases, Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, Beijing 100005, China.

|December 17, 2024

概括

诱导多能干细胞衍生自然杀手 (iPSC-NK) 细胞为癌症治疗提供了对原发性NK细胞和NK-92细胞系的有希望的替代方案. 这些细胞可以被基因改造以提高疗效,并克服当前的治疗限制.

科学领域:

免疫学免疫学免疫学
细胞疗法细胞疗法
癌症研究癌症研究

背景情况:

自然杀手 (NK) 细胞是关键的先天性免疫淋巴细胞,用于消除感染病毒和癌细胞.
目前使用原始细胞或NK-92细胞系的NK细胞疗法面临着限制,如受限的增殖,存储问题和辐射后活动减少.
诱导多能干细胞 (iPSC) 为产生NK细胞提供了一种可再生的来源.

研究的目的:

对iPSC-NK细胞的分化协议的进展进行审查.
突出iPSC-NK细胞治疗在临床应用中的进展和潜力.
讨论iPSC-NK细胞发展的挑战和未来方向.

主要方法:

对用于NK细胞生成的iPSC分化协议的审查.
分析基因修饰策略以增强iPSC-NK细胞功能.
评估目前iPSC-NK细胞疗法的临床进展和挑战.

主要成果:

改进的分化协议使iPSC-NK细胞的有效临床生产成为可能.
对iPSC-NK细胞的基因工程增强了瘤向,扩张和持久性.
与现有的NK细胞疗法相比,iPSC-NK细胞显示出强大的抗瘤功效改善潜力.

结论:

iPSC-NK细胞代表了基于细胞的癌症免疫疗法的重大进步.
对差异化协议的进一步研究和克服挑战将优化iPSC-NK细胞疗法.
对于未来的癌症治疗策略来说,iPSC-NK细胞具有很大的前景.

关键词:

在 NK 细胞中,NK 细胞是 NK 细胞.癌症免疫疗法免疫疗法基因编辑基因编辑诱导多能干细胞 (iPSC) 是一种诱导多能干细胞.

更多相关视频

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Published on: February 8, 2022

Generation of Natural Killer Cells from Human Expanded Potential Stem Cells

Generation of Natural Killer Cells from Human Expanded Potential Stem Cells

Published on: January 13, 2023

相关概念视频

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.